HE
Cybin Inc. Common Stock (HELP)
NASDAQ·Healthcare·Biotechnology
$8.12
+3.71%
Mkt Cap $484.72M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (1 analysts)
$22.00
Range $22.00 – $22.00
Implied Upside
+170.9%
Consensus $22.00 vs current $8.12
NASDAQ·Healthcare·Biotechnology
$8.12
+3.71%
Mkt Cap $484.72M
Buy
3
Hold
0
Sell
0
Price Target (1 analysts)
$22.00
Range $22.00 – $22.00
+170.9%
Consensus $22.00 vs current $8.12